Loading clinical trials...
Loading clinical trials...
Vaccines made from antigens may make the body build an immune response to kill abnormal cervical cells and may be effective in preventing cervical cancer. Randomized phase II trial to study the effect...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Cancer Institute (NCI)
NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more
NCT06079671 · Locally Advanced Cervical Cancer
NCT05639972 · HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, and more
NCT06851663 · Solid Tumor, Solid Carcinoma, and more
NCT05979610 · Gynecologic Neoplasm, Brachytherapy, and more
Gynecologic Oncology Group
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions